Prudential Financial’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-7,326
| Closed | -$210K | – | 2504 |
|
|
2018
Q4 | $210K | Hold |
7,326
| – | – | ﹤0.01% | 2239 |
|
|
2018
Q3 | $204K | Sell |
7,326
-10
| -0.1% | -$281 | ﹤0.01% | 2325 |
|
|
2018
Q2 | $205K | Buy |
+7,336
| New | +$197K | ﹤0.01% | 2341 |
|
|
2017
Q4 | – | Sell |
-7,316
| Closed | -$202K | – | 2378 |
|
|
2017
Q3 | $202K | Buy |
+7,316
| New | +$195K | ﹤0.01% | 2256 |
|
|
2017
Q2 | – | Sell |
-173,972
| Closed | -$4.67M | – | 2401 |
|
|
2017
Q1 | $4.67M | Sell |
173,972
-94,801
| -35% | -$2.62M | 0.01% | 1148 |
|
|
2016
Q4 | $7.04M | Sell |
268,773
-58,123
| -18% | -$1.44M | 0.01% | 976 |
|
|
2016
Q3 | $8.17M | Sell |
326,896
-174,200
| -35% | -$4.06M | 0.01% | 908 |
|
|
2016
Q2 | $10.9M | Buy |
501,096
+176,510
| +54% | +$3.15M | 0.02% | 792 |
|
|
2016
Q1 | $4.87M | Buy |
324,586
+79,500
| +32% | +$1.33M | 0.01% | 1113 |
|
|
2015
Q4 | $5.37M | Sell |
245,086
-62,706
| -20% | -$1.17M | 0.01% | 1043 |
|
|
2015
Q3 | $4.85M | Buy |
307,792
+294,156
| +2,157% | +$4.72M | 0.01% | 1031 |
|
|
2015
Q2 | $195K | Buy |
+13,636
| New | +$231K | ﹤0.01% | 2145 |
|
|
2014
Q3 | – | Sell |
-15,317
| Closed | -$220K | – | 2364 |
|
|
2014
Q2 | $220K | Buy |
+15,317
| New | +$200K | ﹤0.01% | 2272 |
|
Other funds holding NXTM
Prudential Financial's NXTM Position: Q1 2019 in Review
Prudential Financial sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 7,326 shares — an estimated $210K sold.
Prudential Financial first reported a position in NXTM in Q2 2014 and held it in 13 quarters. The position peaked at $10.9M in Q2 2016. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Prudential Financial reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Prudential Financial sold 7,326 NxStage Medical Inc. shares in Q1 2019, an estimated $210K.
- Prudential Financial first reported a position in NxStage Medical Inc. in Q2 2014 and held it in 13 quarters.
- Prudential Financial's NxStage Medical Inc. position peaked at $10.9M in Q2 2016.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Prudential Financial's 13F filing for Q1 2019, filed 15 May 2019.